vs

Side-by-side financial comparison of Dexcom (DXCM) and PATTERSON UTI ENERGY INC (PTEN). Click either name above to swap in a different company.

Dexcom is the larger business by last-quarter revenue ($1.3B vs $1.1B, roughly 1.1× PATTERSON UTI ENERGY INC). Dexcom runs the higher net margin — 21.2% vs -2.2%, a 23.4% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs -12.7%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs -8.4%).

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

Patterson UTI Energy Inc. is a leading oilfield services provider offering onshore contract drilling, pressure pumping, well completion and related support services. It primarily serves upstream oil and gas operators across North America, operating in major unconventional resource basins including shale and tight gas formations.

DXCM vs PTEN — Head-to-Head

Bigger by revenue
DXCM
DXCM
1.1× larger
DXCM
$1.3B
$1.1B
PTEN
Growing faster (revenue YoY)
DXCM
DXCM
+34.3% gap
DXCM
21.6%
-12.7%
PTEN
Higher net margin
DXCM
DXCM
23.4% more per $
DXCM
21.2%
-2.2%
PTEN
Faster 2-yr revenue CAGR
DXCM
DXCM
Annualised
DXCM
12.0%
-8.4%
PTEN

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
DXCM
DXCM
PTEN
PTEN
Revenue
$1.3B
$1.1B
Net Profit
$267.3M
$-24.5M
Gross Margin
62.9%
Operating Margin
25.6%
Net Margin
21.2%
-2.2%
Revenue YoY
21.6%
-12.7%
Net Profit YoY
153.6%
-170.8%
EPS (diluted)
$0.67
$-0.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DXCM
DXCM
PTEN
PTEN
Q1 26
$1.3B
$1.1B
Q4 25
$1.3B
$1.1B
Q3 25
$1.2B
$1.2B
Q2 25
$1.2B
$1.2B
Q1 25
$1.0B
$1.3B
Q4 24
$1.1B
$1.1B
Q3 24
$994.2M
$1.3B
Q2 24
$1.0B
$1.3B
Net Profit
DXCM
DXCM
PTEN
PTEN
Q1 26
$267.3M
$-24.5M
Q4 25
$267.3M
$-9.2M
Q3 25
$283.8M
$-36.4M
Q2 25
$179.8M
$-49.1M
Q1 25
$105.4M
$1.0M
Q4 24
$151.7M
$-51.4M
Q3 24
$134.6M
$-978.8M
Q2 24
$143.5M
$11.1M
Gross Margin
DXCM
DXCM
PTEN
PTEN
Q1 26
62.9%
Q4 25
62.9%
Q3 25
60.5%
Q2 25
59.5%
Q1 25
56.9%
Q4 24
58.9%
Q3 24
59.7%
Q2 24
62.4%
Operating Margin
DXCM
DXCM
PTEN
PTEN
Q1 26
25.6%
Q4 25
25.6%
-0.0%
Q3 25
20.1%
-2.4%
Q2 25
18.4%
-2.4%
Q1 25
12.9%
1.3%
Q4 24
17.0%
-2.7%
Q3 24
15.3%
-73.8%
Q2 24
15.7%
3.4%
Net Margin
DXCM
DXCM
PTEN
PTEN
Q1 26
21.2%
-2.2%
Q4 25
21.2%
-0.8%
Q3 25
23.5%
-3.1%
Q2 25
15.5%
-4.1%
Q1 25
10.2%
0.1%
Q4 24
13.6%
-4.5%
Q3 24
13.5%
-72.9%
Q2 24
14.3%
0.8%
EPS (diluted)
DXCM
DXCM
PTEN
PTEN
Q1 26
$0.67
$-0.06
Q4 25
$0.67
$-0.01
Q3 25
$0.70
$-0.10
Q2 25
$0.45
$-0.13
Q1 25
$0.27
$0.00
Q4 24
$0.37
$-0.10
Q3 24
$0.34
$-2.50
Q2 24
$0.35
$0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DXCM
DXCM
PTEN
PTEN
Cash + ST InvestmentsLiquidity on hand
$917.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.7B
$3.2B
Total Assets
$6.3B
$5.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DXCM
DXCM
PTEN
PTEN
Q1 26
$917.7M
Q4 25
$917.7M
$418.5M
Q3 25
$1.8B
$184.8M
Q2 25
$1.2B
$183.8M
Q1 25
$904.9M
$223.1M
Q4 24
$606.1M
$239.2M
Q3 24
$621.2M
$113.4M
Q2 24
$939.2M
$72.4M
Total Debt
DXCM
DXCM
PTEN
PTEN
Q1 26
Q4 25
$1.2B
Q3 25
$1.2B
Q2 25
$1.2B
Q1 25
$1.2B
Q4 24
$1.2B
Q3 24
$1.2B
Q2 24
$1.2B
Stockholders' Equity
DXCM
DXCM
PTEN
PTEN
Q1 26
$2.7B
$3.2B
Q4 25
$2.7B
$3.2B
Q3 25
$2.7B
$3.2B
Q2 25
$2.6B
$3.3B
Q1 25
$2.3B
$3.4B
Q4 24
$2.1B
$3.5B
Q3 24
$2.0B
$3.6B
Q2 24
$2.4B
$4.6B
Total Assets
DXCM
DXCM
PTEN
PTEN
Q1 26
$6.3B
$5.4B
Q4 25
$6.3B
$5.6B
Q3 25
$7.5B
$5.5B
Q2 25
$7.3B
$5.6B
Q1 25
$6.8B
$5.8B
Q4 24
$6.5B
$5.8B
Q3 24
$6.4B
$6.0B
Q2 24
$6.8B
$7.0B
Debt / Equity
DXCM
DXCM
PTEN
PTEN
Q1 26
Q4 25
0.38×
Q3 25
0.38×
Q2 25
0.37×
Q1 25
0.36×
Q4 24
0.36×
Q3 24
0.35×
Q2 24
0.27×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DXCM
DXCM
PTEN
PTEN
Operating Cash FlowLast quarter
$63.9M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
4.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DXCM
DXCM
PTEN
PTEN
Q1 26
$63.9M
Q4 25
$294.0M
$397.5M
Q3 25
$659.9M
$215.8M
Q2 25
$303.0M
$139.7M
Q1 25
$183.8M
$208.1M
Q4 24
$301.4M
$315.8M
Q3 24
$199.5M
$296.3M
Q2 24
$279.4M
$197.5M
Free Cash Flow
DXCM
DXCM
PTEN
PTEN
Q1 26
Q4 25
$192.1M
$259.0M
Q3 25
$579.4M
$71.3M
Q2 25
$208.9M
$-4.5M
Q1 25
$96.8M
$46.3M
Q4 24
$176.8M
$175.5M
Q3 24
$88.3M
$115.7M
Q2 24
$213.3M
$67.0M
FCF Margin
DXCM
DXCM
PTEN
PTEN
Q1 26
Q4 25
15.3%
22.6%
Q3 25
47.9%
6.1%
Q2 25
18.1%
-0.4%
Q1 25
9.3%
3.7%
Q4 24
15.9%
15.3%
Q3 24
8.9%
8.6%
Q2 24
21.2%
5.0%
Capex Intensity
DXCM
DXCM
PTEN
PTEN
Q1 26
4.9%
Q4 25
8.1%
12.1%
Q3 25
6.7%
12.3%
Q2 25
8.1%
11.9%
Q1 25
8.4%
12.8%
Q4 24
11.2%
12.2%
Q3 24
11.2%
13.5%
Q2 24
6.6%
9.8%
Cash Conversion
DXCM
DXCM
PTEN
PTEN
Q1 26
Q4 25
1.10×
Q3 25
2.33×
Q2 25
1.69×
Q1 25
1.74×
207.11×
Q4 24
1.99×
Q3 24
1.48×
Q2 24
1.95×
17.83×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons